Equities
Health CareMedical Equipment and Services
  • Price (HKD)6.13
  • Today's Change-0.07 / -1.13%
  • Shares traded183.00k
  • 1 Year change+48.43%
  • Beta1.2684
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Peijia Medical Ltd is an investment holding company principally engaged in the provision of interventional procedural medical device. The Company primarily operates its businesses through two segments, Transcatheter Valve Therapeutic Business segment and Neurointerventional Business segment. Transcatheter Valve Therapeutic Business segment is mainly engaged in the business of research and development, manufacturing and sales of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is mainly involved in the business of research and development, manufacturing and sales of neurointerventional procedural medical devices. The Company’s products include commercialized products such as TaurusOne and TaurusElite. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)755.31m
  • Net income in HKD-254.75m
  • Incorporated2012
  • Employees1.04k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Guanze Medical Infrm Indstry (Hldng) Ltd166.94m23.45m2.84bn58.00121.579.5386.6617.010.02460.02460.17640.31360.50732.211.302,928,732.007.239.508.3312.0436.7941.4314.2513.095.2351.530.054434.79-0.21272.03-37.59-5.0824.24--
OrbusNeich Medical Group Holdings Ltd1.32bn317.86m3.03bn1.43k9.500.94848.362.300.38540.38541.603.860.39190.93254.20990,730.909.487.5910.299.0267.9168.6124.1916.079.95--0.010710.026.6511.24-11.8841.6829.71--
MicroTech Medical (Hangzhou) Co Ltd498.59m-31.31m3.07bn645.00--1.39--6.16-0.0751-0.07511.195.290.20153.654.02735,387.90-1.27-4.48-1.38-4.7048.6548.32-6.28-39.298.33--0.0154--36.4846.1349.51--22.22--
Jenscare Scientific Co Ltd15.19m-276.95m3.29bn174.00--3.34--216.43-0.6794-0.67940.03732.360.01250.0508--71,983.88-23.35---24.76--88.09---1,864.69--6.39-854.860.0631------52.25------
Peijia Medical Ltd755.31m-254.75m4.12bn1.04k--1.84--5.45-0.3851-0.38511.143.330.25611.4017.04721,406.10-8.76-26.57-10.02-28.9969.2571.23-34.21-247.651.49-15.300.1396--39.53101.1342.28--83.33--
Acotec Scientific Holdings Ltd670.68m114.15m4.32bn645.0036.802.6424.846.440.37440.37442.235.210.33531.063.531,031,822.005.710.24676.450.28975.2381.3317.020.71225.57--0.14060.0012.6933.72260.8817.7483.44--
MicroPort CardioFlow Medtech Corp415.78m5.49m5.41bn417.00361.230.830650.3113.020.00240.00240.17851.020.14231.001.77966,930.900.0886-13.380.0996-16.8469.0864.410.6228-124.496.50--0.112--7.5475.8589.51--26.60--
Modern Dental Group Ltd3.50bn478.00m5.47bn8.59k11.491.838.761.560.50930.50933.733.190.82979.044.89492,119.5011.428.0813.349.6054.0651.8513.7610.322.7654.800.199940.786.056.990.965120.360.4449--
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd624.75m325.08m5.73bn374.0017.632.5716.039.170.93750.93751.806.440.24940.83236.061,989,648.0012.987.8314.899.2887.2389.1852.0335.625.03--0.000681.7844.4032.2862.2236.4582.59--
Data as of Feb 16 2026. Currency figures normalised to Peijia Medical Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

16.00%Per cent of shares held by top holders
HolderShares% Held
Hillhouse Investment Management Ltd. (Hong Kong)as of 30 Jun 202540.74m6.06%
FIL Investment Management (Hong Kong) Ltd.as of 04 Oct 202437.75m5.62%
Fidelity Management & Research (Hong Kong) Ltd.as of 31 Dec 20257.75m1.15%
FIL Investment Management (Singapore) Ltd.as of 04 Oct 20244.93m0.73%
Fidelity Management & Research Co. LLCas of 31 Dec 20254.77m0.71%
Dimensional Fund Advisors LPas of 05 Feb 20264.42m0.66%
UBS Asset Management (Hong Kong) Ltd.as of 31 Oct 20253.53m0.53%
Norges Bank Investment Managementas of 30 Jun 20252.10m0.31%
FIL Pensions Managementas of 30 Jun 20251.15m0.17%
Value Partners Ltd.as of 30 Jun 2025410.00k0.06%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.